Summary of COUGAR BIOTECHNOLOGY, INC.

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

CGRB > SEC Filings for CGRB > Form 8-K on 20-Nov-2008

All Recent SEC Filings

Show all filings for COUGAR BIOTECHNOLOGY, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for COUGAR BIOTECHNOLOGY, INC.

20-Nov-2008

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.

On November 20, 2008, Cougar Biotechnology, Inc. (the "Company") issued a press release announcing the initiation of a Phase I/II clinical trial of its product candidate CB7630 in patients with advanced breast cancer. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description
99.1 Press release dated November 20, 2008.

Add CGRB to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for CGRB - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.